Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data

As a medicine safety issue, Drug-Drug Interaction (DDI) may become an unexpected threat for causing Adverse Drug Events (ADEs). There is a growing demand for computational methods to efficiently and effectively analyse large-scale data to detect signals of Adverse Drug-drug Interactions (ADDIs). In this paper, we aim to detect high-quality signals of ADDIs which are non-spurious and non-redundant. We propose a new method which employs the framework of Bayesian network to infer the direct associations between the target ADE and medicines, and uses domain knowledge to facilitate the learning of Bayesian network structures. To improve efficiency and avoid redundancy, we design a level-wise algorithm with pruning strategy to search for high-quality ADDI signals. We have applied the proposed method to the United States Food and Drug Administration's (FDA) Adverse Event Reporting System (FAERS) data. The result shows that 54.45% of detected signals are verified as known DDIs and 10.89% were evaluated as high-quality ADDI signals, demonstrating that the proposed method could be a promising tool for ADDI signal detection.

[1]  Constantin F. Aliferis,et al.  Local Causal and Markov Blanket Induction for Causal Discovery and Feature Selection for Classification Part I: Algorithms and Empirical Evaluation , 2010, J. Mach. Learn. Res..

[2]  Jiuyong Li,et al.  Practical Approaches to Causal Relationship Exploration , 2015, SpringerBriefs in Electrical and Computer Engineering.

[3]  Yi-Cheng Tu,et al.  A novel algorithm for analyzing drug-drug interactions from MEDLINE literature , 2015, Scientific Reports.

[4]  R. O. Day,et al.  Drug Interactions of Clinical Importance , 1995, Drug safety.

[5]  Patrick Aloy,et al.  IntSide: a web server for the chemical and biological examination of drug side effects , 2014, Bioinform..

[6]  Sriraam Natarajan,et al.  Drug-Drug Interaction Discovery: Kernel Learning from Heterogeneous Similarities. , 2018, Smart health.

[7]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[8]  Sunil Kumar Sahu,et al.  Drug-Drug Interaction Extraction from Biomedical Text Using Long Short Term Memory Network , 2017, J. Biomed. Informatics.

[9]  Yi Pan,et al.  IDNDDI: An Integrated Drug Similarity Network Method for Predicting Drug-Drug Interactions , 2019, ISBRA.

[10]  Syed Rizwanuddin Ahmad,et al.  Adverse drug event monitoring at the food and drug administration , 2003, Journal of general internal medicine.

[11]  Russ B. Altman,et al.  A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports , 2012, J. Am. Medical Informatics Assoc..

[12]  Christopher C. Yang,et al.  Harnessing Social Media for Drug-Drug Interactions Detection , 2013, 2013 IEEE International Conference on Healthcare Informatics.

[13]  I. Edwards,et al.  Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.

[14]  Lise Getoor,et al.  A probabilistic approach for collective similarity-based drug-drug interaction prediction , 2016, Bioinform..

[15]  César de Pablo-Sánchez,et al.  Using a shallow linguistic kernel for drug-drug interaction extraction , 2011, J. Biomed. Informatics.

[16]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[17]  Bharat T Thakrar,et al.  Detecting signals of drug-drug interactions in a spontaneous reports database. , 2007, British journal of clinical pharmacology.

[18]  Lei Cao,et al.  MARAS: Signaling Multi-Drug Adverse Reactions , 2017, KDD.

[19]  N. Crowther,et al.  Drug interactions among commonly used medications. Chart simplifies data from critical literature review. , 1997, Canadian family physician Medecin de famille canadien.

[20]  Son Doan,et al.  Application of information technology: MedEx: a medication information extraction system for clinical narratives , 2010, J. Am. Medical Informatics Assoc..

[21]  Christopher C. Yang,et al.  Mining a Weighted Heterogeneous Network Extracted from Healthcare-Specific Social Media for Identifying Interactions between Drugs , 2015, 2015 IEEE International Conference on Data Mining Workshop (ICDMW).

[22]  Yang Xiang,et al.  Efficiently mining Adverse Event Reporting System for multiple drug interactions , 2014, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

[23]  R. Sundberg,et al.  A statistical methodology for drug–drug interaction surveillance , 2008, Statistics in medicine.

[24]  W. DuMouchel,et al.  Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting , 2003, Pharmacoepidemiology and drug safety.

[25]  Yong Hu,et al.  Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports , 2017, Artif. Intell. Medicine.

[26]  Feng Liu,et al.  Predicting potential drug-drug interactions by integrating chemical, biological, phenotypic and network data , 2017, BMC Bioinformatics.

[27]  Hongfang Liu,et al.  Standardizing Drug Adverse Event Reporting Data , 2013, MedInfo.

[28]  Carol Friedman,et al.  Drug-drug interaction through molecular structure similarity analysis , 2012, J. Am. Medical Informatics Assoc..

[29]  Guido Zuccon,et al.  Causality Discovery with Domain Knowledge for Drug-Drug Interactions Discovery , 2019, ADMA.

[30]  Stuart J. Nelson,et al.  Normalized names for clinical drugs: RxNorm at 6 years , 2011, J. Am. Medical Informatics Assoc..

[31]  Doheon Lee,et al.  Predicting Pharmacodynamic Drug-Drug Interactions through Signaling Propagation Interference on Protein-Protein Interaction Networks , 2015, PloS one.